Hayashi S, Yamada K
Thrombosis Chemical Institute, Tokyo, Japan.
Blood Coagul Fibrinolysis. 1993 Feb;4(1):153-8.
The region and mechanism of urinary protein C inhibitor (PCI) binding to fibrin(ogen) were examined using fibrin(ogen)-Sepharose and ligand blotting. Urinary PCI bound to fibrin(ogen)-Sepharose in a heparin-dependent manner at a level about 1.6-fold higher to fibrin-Sepharose than to fibrinogen-Sepharose. Scatchard analysis of the binding between urinary PCI and fibrin(ogen)-Sepharose showed that the Kd for fibrin-Sepharose and fibrinogen-Sepharose were 4.0 nM and 5.7 nM respectively. Ligand blotting using urinary PCI and an enzyme-linked immunoassay showed that urinary PCI bound to fibrinogen, fibrinogen degradation products (X, Y, D and E) and the A alpha-, B beta- and gamma-chains of fibrinogen. Binding between urinary PCI and fibrin(ogen)-Sepharose was slightly suppressed (16%) by alpha-methylmannose and largely suppressed (42%) by EACA, which indicates that the carbohydrate chain and the lysine binding site participate in the binding. These findings suggest that urinary PCI binds to fibrin(ogen) via the A alpha-, B beta- and gamma-chains and its binding is partly mediated by carbohydrate and the lysine binding site.
利用纤维蛋白(原)-琼脂糖亲和层析和配体印迹法研究了尿蛋白C抑制剂(PCI)与纤维蛋白(原)的结合区域及机制。尿PCI以肝素依赖的方式与纤维蛋白(原)-琼脂糖结合,与纤维蛋白-琼脂糖的结合水平比与纤维蛋白原-琼脂糖的结合水平高约1.6倍。对尿PCI与纤维蛋白(原)-琼脂糖结合的Scatchard分析表明,与纤维蛋白-琼脂糖和纤维蛋白原-琼脂糖结合的解离常数(Kd)分别为4.0 nM和5.7 nM。使用尿PCI的配体印迹法和酶联免疫分析法表明,尿PCI与纤维蛋白原、纤维蛋白原降解产物(X、Y、D和E)以及纤维蛋白原的Aα、Bβ和γ链结合。α-甲基甘露糖对尿PCI与纤维蛋白(原)-琼脂糖的结合有轻微抑制作用(16%),而6-氨基己酸(EACA)则有较大抑制作用(42%),这表明糖链和赖氨酸结合位点参与了结合。这些发现提示,尿PCI通过Aα、Bβ和γ链与纤维蛋白(原)结合,其结合部分由糖类和赖氨酸结合位点介导。